GeckoSystems Intl. Corp. (GOSY)

[XenaLives]

George MacLeod didn't last very long at GeckoSystems. Neil Wallace got the boot after five months.

During that time they introduced fake investors, defrauded the company and potential legitimate investors, and tried to sell the company's technology for pennies on the dollar.

It seems that MacLeod's track record with PharmEssen was similar, I wonder if he was attending meetings with his Mason buddies and talking about how ethical he was while he was pulling these cons?

Also note that Gerry Berg of "Iggly Piggly Poo" fame was involved here too.

PHARMESSEN EXPERTS

DUSAN G. NINKOV DVM MSc PhD
President & Chairman
original management

GEORGE MACLEOD
CEO

GERRY BERG
CFO

FRANK CHAVIANO
PhD Public Health
VP of Product Development
[e-mail]
http://www.corporationwiki.com/Florida/Boca-Raton/u-s-medical-management-corp-3010629.aspx





WADE STEVERSON
Vice President Sales/Marketing
[e-mail]

EZRA BEJAR MSc PhD
Vice President Research and Development
[e-mail]

WOLFRAM JUNGHANNS BSc MSc PhD
Production Consultant

VESNA SEGOS BSc MSc
Pharmaceutical Consultant





http://web.archive.org/web/20051107224736/http://66.34.178.32/press/press.asp?id=11

Pharmessen Scientific, Inc. Announces Management Changes


SAN DIEGO--(BUSINESS WIRE)--August 30, 2004--Pharmessen Scientific, Inc. (Other OTC: PASC.PK - News), a global nutraceutical research company focused on providing leading supplements for better general health, announced today that founder Dr. Dusan G. Ninkov has resumed his CEO role on an interim basis, a post he held up until February of this year. In connection with this change, the company has relieved its Chief Executive Officer and Chief Financial Officer from their respective positions. Also on an interim basis, the CFO function will be performed with the assistance of the company’s outside accounting firm. The move was part of a larger effort, including a reduction of other administrative personnel, for the purpose of reallocating resources from overhead to sales and production support. "This change in management signals a return to fundamentals, and a re-unification of managerial philosophy with shareholder value," said Dr. Ninkov. "We believe that Pharmessen has not realized sales growth to a level consistent with the quality of its existing product, and we are actively reducing overhead to dedicate all available resources to the company’s sales effort." Consistent with this renewed priority on sales, Pharmessen also announced the appointment of Gabriel Luna de la Fuente as Chief Operating Officer. De la Fuente is a seasoned sales veteran, with successful tenures with Coca-Cola, Champions Sports Memorabilia, Univision Television, and El Informador Magazine. "Pharmessen has an exciting product line, and it has been well-received by the market," says de La Fuente. "My belief is that this company’s growth will and should come from profits, which in turn come from sales. That will be my focus."